Modifiable factors for irritable bowel syndrome: evidence from Mendelian randomisation approach

Background The potential modifiable factors influencing irritable bowel syndrome (IBS) have not been thoroughly documented. We aimed to systematically investigate the modifiable factors associated with IBS, while accounting for the impact of unobserved confounders and coexisting disorders.Methods Ge...

Full description

Saved in:
Bibliographic Details
Main Authors: Jinling Tang, Zhirong Yang, Shanshan Wu, Feng Sha, Tengfei Lin, Di Liu, Meiling Cao, Yiwen Jiang, Weijie Cao, Fuxiao Li
Format: Article
Language:English
Published: BMJ Publishing Group 2025-01-01
Series:eGastroenterology
Online Access:https://egastroenterology.bmj.com/content/3/1/e100126.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856395893604352
author Jinling Tang
Zhirong Yang
Shanshan Wu
Feng Sha
Tengfei Lin
Di Liu
Meiling Cao
Yiwen Jiang
Weijie Cao
Fuxiao Li
author_facet Jinling Tang
Zhirong Yang
Shanshan Wu
Feng Sha
Tengfei Lin
Di Liu
Meiling Cao
Yiwen Jiang
Weijie Cao
Fuxiao Li
author_sort Jinling Tang
collection DOAJ
description Background The potential modifiable factors influencing irritable bowel syndrome (IBS) have not been thoroughly documented. We aimed to systematically investigate the modifiable factors associated with IBS, while accounting for the impact of unobserved confounders and coexisting disorders.Methods Genetic correlation and Mendelian randomisation (MR) analyses were integrated to identify potential modifiable factors and coexisting disorders linked to IBS. Subsequently, multiresponse MR (MR2) was employed to further examine these associations. Summary-level genome-wide association data were used. Modifiable factors and coexisting disorders (ie, gastrointestinal and psychiatric disorders) were identified based on evidence from cohort studies and meta-analysis. In all analyses, IBS was the primary outcome, while in the MR2 analysis, coexisting disorders were also treated as outcomes alongside IBS.Results Most identified modifiable factors and coexisting disorders exhibited genetic correlations with IBS. MR analyses revealed strong causation between IBS and multisite chronic pain (OR=2.20, 95% CI 1.82 to 2.66), gastro-oesophageal reflux disease (OR=1.31, 95% CI 1.23 to 1.39), well-being spectrum (OR=0.17, 95% CI 0.13 to 0.21), life satisfaction (OR=0.31, 95% CI 0.25 to 0.38), positive affect (OR=0.30, 95% CI 0.24 to 0.37), neuroticism score (OR=1.20, 95% CI 1.16 to 1.25) and depression (OR=1.50, 95% CI 1.37 to 1.66). Additionally, smoking, alcohol frequency, college or university degree, intelligence, childhood maltreatment, frailty index, diverticular disease of the intestine and schizophrenia were suggestively associated with IBS. Robust associations were found between multisite chronic pain and both IBS and coexisting disorders.Conclusions Our study identified a comprehensive array of potential modifiable factors and coexisting disorders associated with IBS, supported by genetic evidence, including genetic correlation and multiple MR analyses. The presence of multisite chronic pain may offer a promising avenue for the concurrent prevention of IBS and its coexisting disorders.
format Article
id doaj-art-050dfe1f105c4af497eae7549014e98a
institution Kabale University
issn 2766-0125
2976-7296
language English
publishDate 2025-01-01
publisher BMJ Publishing Group
record_format Article
series eGastroenterology
spelling doaj-art-050dfe1f105c4af497eae7549014e98a2025-02-12T09:15:11ZengBMJ Publishing GroupeGastroenterology2766-01252976-72962025-01-013110.1136/egastro-2024-100126Modifiable factors for irritable bowel syndrome: evidence from Mendelian randomisation approachJinling Tang0Zhirong Yang1Shanshan Wu2Feng Sha3Tengfei Lin4Di Liu5Meiling Cao6Yiwen Jiang7Weijie Cao8Fuxiao Li97 Department of Computational Biology and Medical Big Data, Shenzhen University of Advanced Technology, Shenzhen, Guangdong, China1 Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China3 Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China1 Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China1 Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China1 Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China2 Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China1 Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China6 Edith Cowan University, Joondalup, Western Australia, Australia1 Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, ChinaBackground The potential modifiable factors influencing irritable bowel syndrome (IBS) have not been thoroughly documented. We aimed to systematically investigate the modifiable factors associated with IBS, while accounting for the impact of unobserved confounders and coexisting disorders.Methods Genetic correlation and Mendelian randomisation (MR) analyses were integrated to identify potential modifiable factors and coexisting disorders linked to IBS. Subsequently, multiresponse MR (MR2) was employed to further examine these associations. Summary-level genome-wide association data were used. Modifiable factors and coexisting disorders (ie, gastrointestinal and psychiatric disorders) were identified based on evidence from cohort studies and meta-analysis. In all analyses, IBS was the primary outcome, while in the MR2 analysis, coexisting disorders were also treated as outcomes alongside IBS.Results Most identified modifiable factors and coexisting disorders exhibited genetic correlations with IBS. MR analyses revealed strong causation between IBS and multisite chronic pain (OR=2.20, 95% CI 1.82 to 2.66), gastro-oesophageal reflux disease (OR=1.31, 95% CI 1.23 to 1.39), well-being spectrum (OR=0.17, 95% CI 0.13 to 0.21), life satisfaction (OR=0.31, 95% CI 0.25 to 0.38), positive affect (OR=0.30, 95% CI 0.24 to 0.37), neuroticism score (OR=1.20, 95% CI 1.16 to 1.25) and depression (OR=1.50, 95% CI 1.37 to 1.66). Additionally, smoking, alcohol frequency, college or university degree, intelligence, childhood maltreatment, frailty index, diverticular disease of the intestine and schizophrenia were suggestively associated with IBS. Robust associations were found between multisite chronic pain and both IBS and coexisting disorders.Conclusions Our study identified a comprehensive array of potential modifiable factors and coexisting disorders associated with IBS, supported by genetic evidence, including genetic correlation and multiple MR analyses. The presence of multisite chronic pain may offer a promising avenue for the concurrent prevention of IBS and its coexisting disorders.https://egastroenterology.bmj.com/content/3/1/e100126.full
spellingShingle Jinling Tang
Zhirong Yang
Shanshan Wu
Feng Sha
Tengfei Lin
Di Liu
Meiling Cao
Yiwen Jiang
Weijie Cao
Fuxiao Li
Modifiable factors for irritable bowel syndrome: evidence from Mendelian randomisation approach
eGastroenterology
title Modifiable factors for irritable bowel syndrome: evidence from Mendelian randomisation approach
title_full Modifiable factors for irritable bowel syndrome: evidence from Mendelian randomisation approach
title_fullStr Modifiable factors for irritable bowel syndrome: evidence from Mendelian randomisation approach
title_full_unstemmed Modifiable factors for irritable bowel syndrome: evidence from Mendelian randomisation approach
title_short Modifiable factors for irritable bowel syndrome: evidence from Mendelian randomisation approach
title_sort modifiable factors for irritable bowel syndrome evidence from mendelian randomisation approach
url https://egastroenterology.bmj.com/content/3/1/e100126.full
work_keys_str_mv AT jinlingtang modifiablefactorsforirritablebowelsyndromeevidencefrommendelianrandomisationapproach
AT zhirongyang modifiablefactorsforirritablebowelsyndromeevidencefrommendelianrandomisationapproach
AT shanshanwu modifiablefactorsforirritablebowelsyndromeevidencefrommendelianrandomisationapproach
AT fengsha modifiablefactorsforirritablebowelsyndromeevidencefrommendelianrandomisationapproach
AT tengfeilin modifiablefactorsforirritablebowelsyndromeevidencefrommendelianrandomisationapproach
AT diliu modifiablefactorsforirritablebowelsyndromeevidencefrommendelianrandomisationapproach
AT meilingcao modifiablefactorsforirritablebowelsyndromeevidencefrommendelianrandomisationapproach
AT yiwenjiang modifiablefactorsforirritablebowelsyndromeevidencefrommendelianrandomisationapproach
AT weijiecao modifiablefactorsforirritablebowelsyndromeevidencefrommendelianrandomisationapproach
AT fuxiaoli modifiablefactorsforirritablebowelsyndromeevidencefrommendelianrandomisationapproach